Plain-language definitions grounded in the clinical and regulatory literature.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Neurodegenerative Disease
What it isA progressive movement disorder caused by loss of dopamine-producing neurons. Sleep problems often appear years before the tremor and stiffness that doctors typically diagnose.
Why it mattersUp to 75 percent of people with Parkinson’s experience sleep disturbance. REM sleep behavior disorder, in which people physically act out dreams, often precedes Parkinson’s diagnosis by 10-20 years and may signal early disease.
Think of it like thisThink of the dopamine system as the brain’s smooth-motion controller. Parkinson’s slowly takes that controller offline, but the same disease process also disrupts sleep circuits long before motor symptoms appear.
A progressive neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra pars compacta and alpha-synuclein accumulation (Lewy bodies), producing motor symptoms (bradykinesia, tremor, rigidity) and a wide range of non-motor features including sleep disorders.
MechanismSleep disturbance in Parkinson’s arises from multiple sources: degeneration of brainstem sleep-regulatory nuclei, the disease’s effects on motor control during sleep (causing REM sleep behavior disorder), dopaminergic medications that disrupt sleep architecture, comorbidities such as obstructive sleep apnea, and circadian dysregulation.
Scientific ConsensusSleep disorders are common across all stages of Parkinson’s disease. RBD strongly predicts later parkinsonism and other alpha-synucleinopathies. Excessive daytime sleepiness, insomnia, and circadian disruption affect quality of life and disease progression.
Active DebateWhether RBD-targeted neuroprotection can prevent or delay Parkinson’s onset. The optimal pharmacological strategy for Parkinson’s-related insomnia given the complex interactions with dopaminergic medications. The role of sleep in disease progression vs sleep as a passive marker of degeneration.
Emerging ResearchRBD as a window for neuroprotective intervention before motor symptom onset. Wearable sensors and home polysomnography for tracking Parkinson’s-related sleep changes. Targeted sleep treatments showing efficacy.
Key ResearchSchenck et al. (1986) first described RBD. Postuma et al. established the long prodromal phase between RBD onset and Parkinson’s diagnosis. Iranzo et al. (2024) and Stefani and Hogl (2019) provide current canonical reviews of sleep in Parkinson’s disease.
— Current canonical review of sleep disorders across the Parkinson disease spectrum
Stefani, A., Hogl, B. (2020). Sleep in Parkinson disease. Neuropsychopharmacology, 45(1), 121-128.
— Differential diagnosis and management of sleep disorders in Parkinson disease
Sleep disorders, PTSD, and the invisible wounds of service can feel isolating. If you or someone you know is in crisis or experiencing thoughts of self-harm, help is available right now. The Veterans Crisis Line provides free, confidential support 24 hours a day, 7 days a week to veterans, service members, and their families.
If you are in crisis or experiencing thoughts of self-harm, call the Veterans Crisis Line at